Novel immunotherapy approved for melanoma : vimarsana.com

Amtagvi is the first tumour-derived autologous T cell immunotherapy therapy to be approved by the US Food and Drug Administration for certain adults with unresectable or metastatic...

Related Keywords

Philadelphia , Pennsylvania , United States , Jason Bock , Alexander Shoushtari , Frederick Vogt , Peter Marks , Steven Rosenberg , Iovance Biotherapeutics , Surgery Branch , Cell Therapy Manufacturing Center , National Cancer Institute , Russell Publishing , Cellular Therapy Service , Memorial Sloan Kettering Cancer Center , Drug Administration , Biologics Evaluation , Cancer Institute , Interim Chief Executive Officer , Jae Park , Melanoma Oncologist , Cellular Therapist , Sloan Kettering Cancer Center , European Pharmaceutical , Russell Publishing Limited ,